UK Lucentis Biosimilar Nod Offers Teva Potential First-Mover Advantage
Formycon-Bioeq Partnered Ongavia Receives First European Approval In UK
• By David Wallace
The UK has given Teva and partner Formycon a first European ranibizumab approval • Source: Shutterstock 
